Evidence map›Paper›PMID 31798962›Full record

ArticleNPJ systems biology and applications2019

Multi-dimensional computational pipeline for large-scale deep screening of compound effect assessment: an in silico case study on ageing-related compounds.

Vipul Gupta, Alina Crudu, Yukiko Matsuoka, Samik Ghosh, Roger Rozot, Xavier Marat, Sibylle Jäger, Hiroaki Kitano, Lionel Breton

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vipul Gupta1The Systems Biology Institute, Tokyo, Japan.
Alina CruduL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Yukiko Matsuoka1The Systems Biology Institute, Tokyo, Japan.ORCID 0000-0002-5171-9096
Samik Ghosh1The Systems Biology Institute, Tokyo, Japan.
Roger RozotL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Xavier MaratL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Sibylle JägerL'Oréal Research and Innovation, Aulnay-sous-Bois, France.
Hiroaki Kitano1The Systems Biology Institute, Tokyo, Japan.
Lionel BretonL'Oréal Research and Innovation, Aulnay-sous-Bois, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Designing alternative approaches to efficiently screen chemicals on the efficacy landscape is a challenging yet indispensable task in the current compound profiling methods. Particularly, increasing regulatory restrictions underscore the need to develop advanced computational pipelines for efficacy assessment of chemical compounds as alternative means to reduce and/or replace in vivo experiments. Here, we present an innovative computational pipeline for large-scale assessment of chemical compounds by analysing and clustering chemical compounds on the basis of multiple dimensions-structural similarity, binding profiles and their network effects across pathways and molecular interaction maps-to generate testable hypotheses on the pharmacological landscapes as well as identify potential mechanisms of efficacy on phenomenological processes. Further, we elucidate the application of the pipeline on a screen of anti-ageing-related compounds to cluster the candidates based on their structure, docking profile and network effects on fundamental metabolic/molecular pathways associated with the cell vitality, highlighting emergent insights on compounds activities based on the multi-dimensional deep screen pipeline.

Indexed as

AlgorithmsCluster AnalysisComputational BiologyComputer SimulationDrug DiscoveryHigh-Throughput Screening AssaysMetabolic Networks and PathwaysMolecular Docking SimulationSoftwareBiochemical networksSoftwareTarget identificationVirtual drug screening

Identifiers

PMID31798962
PMCPMC6879499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.